Frontlight ResearchEarly access
Trial site
Obudai Egeszsegugyi Centrum Kft
- 4running trials
- 8closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)2 trials
- Atrial fibrillation2 trials
- Obesity2 trials
- Ankylosing spondylitis1 trial
- Chronic spontaneous urticaria1 trial
- Heart failure1 trial
- Hidradenitis suppurativa1 trial
- Osteoporosis1 trial
- Psoriasis1 trial
- Psoriatic arthritis1 trial
- Phase
- Phase 311 trials
- Phase 21 trial
- Status
- Completed7 trials
- Active, not recruiting4 trials
- Withdrawn1 trial
- Lead sponsor
- Amgen2 trials
- ACELYRIN Inc.1 trial
- Alfasigma S.p.A.1 trial
- Amgen Inc.1 trial
- Anthos Therapeutics, Inc.1 trial
- and 6 more
Running trials
Active, not recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Recruiting
Active, not recruiting
Closed trials
Completed
Efficacy, safety, PK, PD, and immunogenicity of BP16 in post-menopausal osteoporosis
Completed
Terminated
Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Active, not recruiting
A Study Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis
Completed
Completed
A Phase 2 Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026